FDA Inspection
North American Custom Laboratories, LLC dba FarmaKeio Superior Custom CompoundingFDA Inspection 1280796 - North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding - September 05, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding, with an inspection on September 5, 2025, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- September 5, 2025
- Product Type
- Human Drugs
- Office
- Dallas District Office
Open in Dashboard
ID · c27b65d6-4ba0-4c25-8c22-7de5cfd3de16
Violation Codes5
21 CFR 110.35(a)21 CFR 110.35(d)21 CFR 110.80(b)(2)21 CFR 110.93FD&C Act 501(a)(2)(A)
Full citation text and observation details available on the Dashboard.